Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.35 USD | -0.46% |
|
+7.94% | -30.62% |
05-14 | Transcript : ScPharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024 | |
05-14 | ScPharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 136
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100.0
%
| 0 | nan % | 14 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 14 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
John Tucker
CEO | Chief Executive Officer | 61 | 16-12-31 |
Rachael Nokes
DFI | Director of Finance/CFO | 49 | 14-08-31 |
John Mohr
CTO | Chief Tech/Sci/R&D Officer | - | 17-01-31 |
Mike Hassman
CTO | Chief Tech/Sci/R&D Officer | - | 18-05-31 |
Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 78 | 13-12-31 | |
Klaus Veitinger
BRD | Director/Board Member | 62 | 17-11-20 |
John Tucker
CEO | Chief Executive Officer | 61 | 16-12-31 |
Frederick Hudson
BRD | Director/Board Member | 78 | 18-06-18 |
William Abraham
BRD | Director/Board Member | 64 | 21-02-15 |
Jack Khattar
CHM | Chairman | 62 | 16-07-11 |
Mette Agger
BRD | Director/Board Member | 59 | 14-02-28 |
Director/Board Member | 76 | 18-07-23 | |
Sara Bonstein
BRD | Director/Board Member | 43 | 20-07-07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 36,054,409 | 29,305,535 ( 81.28 %) | 0 | 81.28 % |
Company contact information
scPharmaceuticals, Inc.
25 Burlington Mall Road Suite 203
01830, Burlington
+617 517 0730
http://www.scpharmaceuticals.com![address scPharmaceuticals Inc.(SCPH)](https://cdn.zonebourse.com/static/address/38721287.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.62% | 157M | |
+55.32% | 815B | |
+44.05% | 641B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+2.04% | 224B | |
+13.31% | 218B | |
+8.48% | 168B |
- Stock Market
- Equities
- SCPH Stock
- Company scPharmaceuticals Inc.